• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Solution Center
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Solution Center
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Pharma Supply Chains: From Fragile to Agile

    Advanced Manufacturing and a Roadmap to the Facility of the Future

    Solving Pharma’s Underlying Rebate Leakage Problem

    Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges

    Revolutionizing Pharma’s Supply Chain
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Univercells Expands into the U.S. With New Offices in Andover, MA

    Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat

    Sanner Group Opens Second Manufacturing Facility in China

    Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems

    Merck KGaA, Quris-AI Expand Collaboration
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Univercells Expands into the U.S. With New Offices in Andover, MA

    Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat

    Sanner Group Opens Second Manufacturing Facility in China

    Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems

    "3 Key Trends" with Srinivasan Shanmugam
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Pharmaceutical Continuous Manufacturing: USP Technical Guide

    Mikart Expands Production and Packaging Capabilities

    Flavor Masking for Rx and OTC Drugs

    Prefilled Syringe Production: Filling a Need with Modern Equipment

    Making the Complex, Simple: A Roadmap for Your OSD Journey
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat

    Modern Partnerships with CROs

    Merck KGaA, Quris-AI Expand Collaboration

    BioCity, AstraZeneca Partner on Treatment of Advanced HCC

    Sartorius, SPARTA Biodiscovery Partner on Nanoparticle Analysis Platform
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges

    Rentschler Biopharma’s ATMP UK Facility Receives MHRA Approval

    Aurisco's Manufacturing Site in China Clears FDA Inspection

    LighthouseAI Secures $2.25M Investment to Grow Supply Chain Products

    Valisure, DoD Conduct Pharmaceutical Quality Risk Assessment Study
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Quotient Sciences

    LOTTE BIOLOGICS

    CMC Pharmaceuticals

    Federal Equipment Company

    Syngene International Ltd.
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Quotient Sciences

    LOTTE BIOLOGICS

    CMC Pharmaceuticals

    Federal Equipment Company

    Syngene International Ltd.
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Microsites
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Pharmaceutical Excipients Trends

    They’re not just unimportant background noise anymore.

    Pharmaceutical Excipients Trends
    Emil W. Ciurczak, DoraMaxx Consulting04.05.19
    I was impressed that there was at least one full session dedicated to the role of excipients in Pharma manufacturing at the recent IFPAC meeting held March 3-6, 2019 in North Bethesda, MD. For many decades, too many formulators viewed excipients as needed, but not glamorous ingredients for their solid dosage forms. Over the last few decades, a number of things happened allowing us to shed light on their chemical and physical properties.

    First, with the introduction of Near-Infrared Spectroscopy to Pharma (c.1984), physical parameters, such as mean particle size, moisture, degree of crystallinity, and polymorphic forms, were easily discerned with a short, non-destructive scan. The speed of NIRS vs. “traditional” (compendial) methods brought them from “occasionally performed” on combined samples (from numerous parts of a single lot) into the “easily performed on each container” for every lot of incoming material.

    Second, mega-products happened. When a typical lot of dosage forms was a few thousand to a few hundred thousand, production personnel experienced fewer problems with flowability or particle size distribution. As batch sizes increased to the millions, hoppers and tablet presses became larger and the granulation/mixture became used/dispensed more quickly. This meant the powders/granules not only had to flow more smoothly at a faster speed, but were exposed to higher vibrations, causing stratification, cavitation, and other physical problems.

    Third, in-line measurements started being made. While real-time measurements were not new to the rest of the world—e.g., mid-range IR in paper mills to control water in paper rolls, NIR for controlling nicotine in cigarettes—they weren’t formally introduced until Pfizer underwrote the creation of a wireless NIR unit for blend uniformity testing and control. In the 1980s, NIRSystems hardened their lab-based unit (model 6500) in a NEMA enclosure for production applications. While the NIRSystems unit was not used for in-line solids measurements, the unit did have fiber-optic probes, capable of following chemical (polymerization, chemical syntheses) and biological reactions (fermentations).

    Fourth, as both instruments and the available software (and computers) became faster and better, faster and better spectra were being taken. Blend uniformity only required one measurement every 10-15 seconds; moisture measurements in a fluid bed drier could take several seconds, since the average is good enough; and following a pan-coating process is also an average measurement, so several seconds per measurement is sufficient. But, real-time measurements of solid dosage forms were not happening, yet.

    Fifth, as diode-array and acousto-optic tunable filter instruments were introduced, measurements in the reflectance more became faster and faster. It was possible, as early as 1992, to measure the moisture content in freeze-dried vials as they came down the line from the lyophilizer. Tablets and capsules could be analyzed, but only more slowly than generated, in real time.

    Sixth, one breakthrough that enabled fast, fast measurements was the ability to make rapid optical measurements. A few years back Innopharma introduced its instrument for evaluating particles as they are produced or as fast as they fall past the optical window. Two years ago, Redstart was introduced. This device was designed to measure the growth of pellets as they are coated in a dynamic process (e.g., a Wurster coater) at a rate of at least one million particles per minute. Both devices show size and shape distributions in real time. Since so many granulations are milled and bulk raw materials sieved, these are good ways to follow the size of both granulations or raw materials size parameters.

    Lastly, thanks to some excellent R&D by the Finnish research institute VTT, a methodology initially introduced as an imaging technique, allows for exceedingly rapid measurements. Of course, the “flaw” was that it was a line-measuring device and the head needed to move. There was a brief time lapse until some engineer remembered that product came off a line moving. It was, after the fact, a simple deduction to have the line move under the device, then add fiber optics and multiple heads (Indatech, Montpelier, France) and you can analyze moving materials in real time (for tablets, 100,000 units per minute per probe).

    What’s the point?
    What does all this have to do with raw materials and their properties? In short, with PAT and QbD becoming more common, there is a great need to precisely characterize all the chemical and physical properties of all the materials used in manufacturing.

    Why now?
    It has nothing to do with suddenly caring, just that now, more things matter to a production engineer. There are several very critical differences between batch manufacturing and QbD, and eventually continuous manufacturing (CM):

    1. Batch processing begins with simply dumping (excuse me: “loading”) all the materials into the device used for blending. The most critical parts of the GMP approach are to:
    a. Assure the correct weights/volumes are added; and
    b. Closely follow the order of addition, as outlined in the MMF (master manufacturing formula).
    2. In batch processing, the materials are physically moved from step one to step two, etc., by hand, so characteristics, such as flowability, are not critical. When we get to the tableting, the mass of ingredients often has been granulated—API spread across the agglomerated mass—and sized to a pre-determined diameter. This lubricated, flowing powder is usually nearly identical and usually flows properly into the tablet press or encapsulating machine.
    3. When there are problems with tablets in a batch process, in theory, you are not allowed to make changes in the MMF. I was part of a study, several years ago, where an independent consulting firm was following the source of failed batches at a company. It was seen that the greatest number of failed lots occurred when the newest operators were on duty. Despite an initial thought that these people needed training, it was uncovered that more experienced personnel made “needed” changes in the printed method, while newer people followed the “menu” as written. Under GMP, you cannot make the changes encouraged under QbD.
    4. If we follow a QbD program, the parameters are allowed to change, but only within what we call Design Space (DS). DS, determined experimentally, consists of a series of allowable changes to operating and chemical parameters, changed to assure that variations in raw materials and instrument variability are noted and the process changed to compensate.

    Moving forward
    If we are to move to QbD (powered by PAT) and, eventually CM, we need to massively change the way in which we evaluate incoming raw materials—excipients and APIs. Currently, we are tied to compendial methods for “qualifying” incoming raw materials. Why is this a problem?

    1. Compendial methods were mostly written to ensure identity and purity of raw materials. There was never an effort to place tests of processability into, for example, the USP.
    a. One test for the ID of lactose is ‘boil in a copper salt solution; if the color turns red, that is proof of a reducing sugar.’ There are also refractive index and heavy metal tests, but nothing to describe useful physical parameters.
    b. The particle size is determined by sieve analysis. Years ago, we had a problem with content uniformity of caffeine. While it was sold as 80, 100, or 120 mesh, it was eventually shown to all be micronized, only holding together through static cling. Just imagine what this would do to a continuous manufacturing process.
    2. In short, all compendial methods were written assuming that raw materials were either generated by the company, itself (API synthesis) or purchased in the same country, under the auspices of the EMA, FDA, etc. All I will say on this point is: multi-country supply chain.

    So, what can be done?
    Basically, we need to change to meaningful tests for:
    1. Particle size: reliable methods such as LASER light scattering or newer rapid optical measurements.
    2. Flowability: now, with CM, a critical parameter. One very nice technique is practiced at Rutgers School of Engineering. They designed a cylinder (diameter ~1/3 m; length ~1 meter) with transparent end windows. This is filled to about one quarter volume and rotated along its long axis (horizontally). With a series of detectors at one end and LEDs at the other, the slow rotation causes the powder to display its ability to cascade, a measure of flowability.
    3. Crystallinity and polymorphic state: not considered necessary under most GMP applications, but critical to QbD. Simple Near-Infrared or Raman scans can inform the production staff of how to modify the feeders for CM or the speed of a blender, etc.

    In short, excipients, or “innocent bystanders,” are neither. Since more and more companies are moving to using PAT to control a QbD, there is and will be a need for more updating of information gleaned from raw materials. Since most raw material suppliers are not likely to change their manufacturing procedures, one answer could be to characterize incoming materials and mark them as to which products and processes they might be assigned. That is a “patch,” and ultimately cooperation with raw material suppliers is needed. But, that’s a topic for another day.


    Emil W. Ciurczak
    DoraMaxx Consulting

    Emil W. Ciurczak has worked in the pharmaceutical industry since 1970 for companies that include Ciba-Geigy, Sandoz, Berlex, Merck, and Purdue Pharma, where he specialized in performing method development on most types of analytical equipment. In 1983, he introduced NIR spectroscopy to pharmaceutical applications, and is generally credited as one of the first to use process analytical technologies (PAT) in drug manufacturing and development.
    Related Searches
    • supply chain
    • Development
    • Pharma
    • API
    Suggested For You
    Biosynth Biosynth
    Legacy Pharma Solutions Legacy Pharma Solutions
    MedPharm MedPharm
    PCI Pharma Services PCI Pharma Services
    Coriolis Pharma Coriolis Pharma
    Catalent Pharma Solutions Catalent Pharma Solutions
    Mogene Mogene
    Regis Custom Pharma Regis Custom Pharma
    Softweb Solutions Softweb Solutions
    Reed-Lane Reed-Lane
    Vetio Animal Health Vetio Animal Health
    Adare Pharma Solutions Adare Pharma Solutions
    KASA to Support Generic Drug Review KASA to Support Generic Drug Review
    The Embedded CDMO The Embedded CDMO
    The Premier Source for Pharmaceutical Process and Packaging Equipment The Premier Source for Pharmaceutical Process and Packaging Equipment

    Related Buyers Guide Companies

    • Biosynth

      Biosynth

      ...
      Aimee Cossins, Marketing 11.08.22

    • Legacy Pharma Solutions

      Legacy Pharma Solutions

      ...
      Nathan Bender, Director, Sales & Marketing 12.07.21

    • MedPharm

      MedPharm

      ...
      Andie Woodson, Marketing Manager 10.21.21


    • Drug Development
      PCI Pharma Services

      PCI Pharma Services

      ...
      Tania Moorehead, Global Marketing Manager 10.20.21

    • Coriolis Pharma

      Coriolis Pharma

      ...
      Bettina von Klitzing-Stu00fcckle 07.01.21

    Loading, Please Wait..
    Breaking News
    • Univercells Expands into the U.S. With New Offices in Andover, MA
    • Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat
    • Sanner Group Opens Second Manufacturing Facility in China
    • Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems
    • Merck KGaA, Quris-AI Expand Collaboration
    View Breaking News >
    CURRENT ISSUE

    September 2023

    • Pharma Supply Chains: From Fragile to Agile
    • Overcoming Stressors in Knowledge Transfer
    • Innovations in Pharma Packaging
    • HPAPI Manufacturing Trends
    • Sustainable Packaging in Pharma: No Longer a Pipe Dream
    • Revolutionizing Pharma’s Supply Chain
    • Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges
    • Solving Pharma’s Underlying Rebate Leakage Problem
    • Advanced Manufacturing and a Roadmap to the Facility of the Future
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    PLT Health Solutions Granted Claims for Botanical Ingredient in Canada
    CRN Files Petition with FTC For Clarity on Health Products Compliance Guidance
    Vitafoods Europe Relocates to Barcelona Starting 2025
    Coatings World

    Latest Breaking News From Coatings World

    California Sports Surfaces Celebrates 70 Years
    ROSS Offers Cost-Effective, Expertly Reconditioned Equipment
    AkzoNobel Shares Sustainable Architectural Solutions at Conference
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    SeaStar Medical Gets Breakthrough Nod for Selective Cytopheretic Device
    ResMed, Nyxoah Team Up to Grow Sleep Apnea Awareness & Therapy in Germany
    Siemens Healthineers’ Magnetom Viato.Mobile Cleared by FDA
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Univercells Expands into the U.S. With New Offices in Andover, MA
    Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat
    Sanner Group Opens Second Manufacturing Facility in China
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    YSL Beauty Taps Finn Wolfhard, Lil Yachty & More for Fragrance Campaign
    74% of Makeup Users Open to Affordable ‘Dupes,’ Mintel Says
    Stoelzle Glass Group Names New CEO
    Happi

    Latest Breaking News From Happi

    Breakfast with Oral Care Benefits?
    Stanford Researchers Study Skin and Sensorial Perception
    L’Oréal Awarded US Patent for Makeup
    Ink World

    Latest Breaking News From Ink World

    Siegwerk’s Climate Targets Validated by SBTi
    ROSS Offering Cost-Effective, Expertly Reconditioned Equipment
    Amcor plc Adds Lucrèce Foufopoulos-De Ridder to Board of Directors
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    SABIC and partners launch bio-based IML solution for food packaging
    tesa completes expansion of Michigan manufacturing facility
    Comexi and Asahi to host 'Effortless Platemaking' event
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Greentech Introduces Air Filter with Advanced Odor Elimination
    Ontex Divests Pakistan Operations to ASAIA Holding
    Goodnites Bedwetting Underwear Recognized by Good Housekeeping
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ChitogenX Granted New U.S., Canadian ORTHO-R Patent
    Centinel Spine prodisc System Surpasses 2,500-Implant Milestone
    Medacta Completes First U.S. MyPAO Hip Surgery
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Jabil Posts Fourth Quarter, Fiscal Year 2023 Results
    Ink-Borne ‘Chiplets’ Could Lead to Printable Displays, Electronics and More
    SCHOTT Strengthens Glass Substrate Portfolio

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login